Works about ALKYLATING agents


Results: 1970
    1
    2
    3
    4
    5
    6

    Symmetric Aromatic Amidoalkylations of Triphenylenes.

    Published in:
    Chemistry - A European Journal, 2024, v. 30, n. 54, p. 1, doi. 10.1002/chem.202402348
    By:
    • Lorenzetto, Tommaso;
    • Berton, Giacomo;
    • Castellini, Francesco;
    • Casson, Gabriele;
    • Scarso, Alessandro;
    • Fabris, Fabrizio
    Publication type:
    Article
    7
    8
    9
    10
    11

    Die katalytische asymmetrische α-Benzylierung von Aldehyden.

    Published in:
    Angewandte Chemie, 2014, v. 126, n. 1, p. 286, doi. 10.1002/ange.201306037
    By:
    • List, Benjamin;
    • Čorić, Ilija;
    • Grygorenko, Oleksandr O.;
    • Kaib, Philip S. J.;
    • Komarov, Igor;
    • Lee, Anna;
    • Leutzsch, Markus;
    • Chandra Pan, Subhas;
    • Tymtsunik, Andrey V.;
    • van Gemmeren, Manuel
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 559, doi. 10.1007/s00280-009-1196-1
    By:
    • Loupakis, Fotios;
    • Masi, Gianluca;
    • Fornaro, Lorenzo;
    • Vasile, Enrico;
    • Allegrini, Giacomo;
    • Fontana, Eloise;
    • Granetto, Cristina;
    • Salvatore, Lisa;
    • Mentuccia, Lucia;
    • Andreuccetti, Michele;
    • Cortesi, Enrico;
    • Merlano, Marco;
    • Cascinu, Stefano;
    • Falcone, Alfredo
    Publication type:
    Article
    24
    25

    Additive effects of drug transporter genetic polymorphisms on irinotecan pharmacokinetics/pharmacodynamics in Japanese cancer patients.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 1, p. 95, doi. 10.1007/s00280-009-1138-y
    By:
    • Sai, Kimie;
    • Saito, Yoshiro;
    • Maekawa, Keiko;
    • Kim, Su-Ryang;
    • Kaniwa, Nahoko;
    • Nishimaki-Mogami, Tomoko;
    • Sawada, Jun-ichi;
    • Shirao, Kuniaki;
    • Hamaguchi, Tetsuya;
    • Yamamoto, Noboru;
    • Kunitoh, Hideo;
    • Ohe, Yuichiro;
    • Yamada, Yasuhide;
    • Tamura, Tomohide;
    • Yoshida, Teruhiko;
    • Matsumura, Yasuhiro;
    • Ohtsu, Atsushi;
    • Saijo, Nagahiro;
    • Minami, Hironobu
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3 and UGT1A1 polymorphisms.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1075, doi. 10.1007/s00280-008-0700-3
    By:
    • Font, Albert;
    • Salazar, Ramon;
    • Maurel, Joan;
    • Taron, Miquel;
    • Ramirez, Jose Luis;
    • Tabernero, Josep;
    • Gallego, Rosa;
    • Casado, Esther;
    • Manzano, Jose Luis;
    • Carcereny, Enric;
    • Guix, Marta;
    • Fernández-Llamazares, Jaume;
    • Rosell, Rafael
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Oxaliplatin activity in head and neck cancer cell lines.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 3, p. 301, doi. 10.1007/s00280-004-0847-5
    By:
    • Espinosa, Magali;
    • Martinez, Moises;
    • Aguilar, Josá;
    • Mota, Aída;da;
    • Garza, Jaime;
    • Maldonado, Vilma;
    • Meléndez-Zajgla, Jorge
    Publication type:
    Article